ProQR Therapeutics N.V. (PRQR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.33M | -13.07M | -12.23M | -11.4M | -15.8M | -9.35M | -5.66M | -6.26M | -15.13M | -5.32M | -7.51M | -10.35M |
| Operating CF Margin % | -548.2% | -281.53% | -419.73% | -298.69% | -349.59% | -217.04% | -147.2% | -99.22% | -340.04% | -162.06% | -548.03% | -832.42% |
| Operating CF Growth % | 28.29% | -39.86% | -116.28% | -82.24% | -4.4% | -75.65% | 24.65% | 39.54% | -133.83% | 70.16% | 51.13% | 30.3% |
| Net Income | -13.6M | -8.84M | -11.01M | -12.18M | -10.08M | -9.3M | -8.11M | -2.69M | -7.66M | -5.48M | -5.42M | -7.98M |
| Depreciation & Amortization | 705.41K | 672.63K | 671K | 675K | 678K | 671K | 688K | 711K | 691K | 728K | 642K | 594K |
| Stock-Based Compensation | 0 | 0 | 1.12M | 909K | 758K | 568K | 612K | 628K | 736K | 802K | 444K | 765K |
| Deferred Taxes | 0 | 0 | 0 | 18K | 0 | 0 | 0 | -200K | 3K | 5K | -83K | 0 |
| Other Non-Cash Items | 1.46M | 1.43M | 57K | 354K | -434K | -739K | 34K | -89K | 320K | -3.67M | -1.08M | -107K |
| Working Capital Changes | 110.79K | -6.34M | -3.07M | -1.18M | -6.72M | -543K | 1.12M | -4.61M | -9.22M | 2.3M | -2.01M | -3.62M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -166.7K | -519.09K | -169K | -101K | -224K | -2.79M | 16.71M | -267K | -17.73M | 5M | -339K | -294K |
| Capital Expenditures | -166.7K | -519.09K | -169K | -101K | -224K | -133K | -286K | -267K | -732K | -602K | -339K | -294K |
| CapEx % of Revenue | 8.07% | 11.18% | 5.8% | 2.65% | 4.96% | 3.09% | 7.44% | 4.23% | 16.45% | 18.33% | 24.74% | 23.65% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -2.65M | 0 | 0 | 0 | 5.6M | 0 | 0 |
| Cash from Financing | -309K | -588.44K | -444K | -293K | -500K | 71.43M | -453K | -282K | -419K | -1.09M | -281K | -643K |
| Debt Issued (Net) | -304K | -601K | -444K | -293K | -567K | -253K | -454K | -294K | -581K | -1.29M | -432K | -647K |
| Equity Issued (Net) | 0 | 1.71K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -5K | 10.85K | 0 | 0 | 67K | 71.68M | 1K | 12K | 162K | 199K | 151K | 4K |
| Net Change in Cash | -13.12M | -14.51M | -12.88M | -12.65M | -16.99M | 60.01M | 10.43M | -6.74M | -33.21M | -1.63M | -8.01M | -10.42M |
| Free Cash Flow | -11.49M | -13.59M | -12.4M | -11.5M | -16.02M | -9.48M | -5.94M | -6.52M | -15.86M | -5.92M | -7.85M | -10.64M |
| FCF Margin % | -556.27% | -292.7% | -425.52% | -301.34% | -354.55% | -220.13% | -154.64% | -103.46% | -356.49% | -180.39% | -572.77% | -856.07% |
| FCF Growth % | 28.26% | -43.37% | -108.72% | -76.33% | -1% | -60.04% | 24.26% | 38.7% | -135.58% | 66.76% | 49.73% | 29.41% |
| FCF per Share | -0.11 | -0.13 | -0.11 | -0.11 | -0.15 | -0.12 | -0.07 | -0.08 | -0.19 | -0.08 | -0.10 | -0.13 |
| FCF Conversion (FCF/Net Income) | 0.83x | 1.48x | 1.11x | 0.94x | 1.57x | 1.00x | 0.70x | 2.32x | 1.98x | 0.97x | 1.31x | 1.29x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |